Annual Summary of Disease Activity:
Disease Control Newsletter (DCN)
- DCN Home
- Annual Summary, 2022
- Annual Summary, 2021
- Annual Summary, 2020
- Annual Summary, 2019
- Annual Summary, 2018
- Annual Summary, 2017
- Annual Summary, 2016
- Annual Summary, 2015
- Annual Summary, 2014
- Annual Summary, 2013
- Annual Summary, 2012
- Annual Summary, 2011
- Annual Summary, 2010
- Annual Summary, 2009
- Annual Summary, 2008
- Annual Summary, 2007
- Annual Summary, 2006
- Annual Summary, 2005
- Annual Summary, 2004
- Annual Summary, 2003
- Annual Summary, 2002
- Annual Summary, 2001
- Annual Summary, 2000
- Annual Summary, 1999
- Annual Summary, 1998
- Annual Summary, 1997
Related Topics
Contact Info
Legionellosis, 2006
During 2006, there were 27 confirmed cases of legionellosis (Legionnaires’ disease [LD]) reported. This included 11 cases (41%) among residents of the metropolitan area and 16 cases (59%) among Greater Minnesota residents. Four (15%) case-patients died. Older adults and elderly persons were more often affected, with 20 (74%) cases occurring among individuals aged 50 years and over (median age, 56 years; range, 31 to 85 years). Ten (37%) cases reported onset dates in June through September. Travel-associated legionellosis accounted for 14 (52%) cases, defined as spending at least 1 night away from the case’s residence in the 10 days before onset of illness.
Confirmed LD case criteria includes X-ray confirmed pneumonia and positive results for one or more of the following tests: culture of Legionella sp., or detection of L. pneumophila, serogroup 1 infection by Legionella urinary antigen, direct fluorescent antigen, or by acute and convalescent antibody titers with a four-fold or greater rise to >1:128. A single antibody titer at any level is not of diagnostic value for LD. For detection of LD, the Infectious Diseases Society of America treatment guidelines for community-acquired pneumonia recommend urinary antigen assay and culture of respiratory secretions on selective media (http://www.journals.uchicago.edu/CID/journal/issues/v37n11/32441/32441.html). Culture is particularly useful because environmental and clinical isolates can be compared by molecular typing in outbreaks and in investigations of health care-associated LD. Starting in 2005, CDC recommended routine assessment of travel history among LD cases so that travel-associated LD clusters or outbreaks could be more readily and quickly detected. Clinical guidance on legionellosis and other resources can be found at: CDC: Legionella (Legionnaires' Disease and Pontiac Fever) Publications.
- For up to date information see>> Legionellosis
- Full issue>> Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2006